Quick Dispatch:
Your glp-1 masld GLP-1 and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) | Current Hepatology Reports orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 masld GLP-1 and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) | Current Hepatology Reports ships.
Need Help?
Questions about glp-1 masld GLP-1 and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) | Current Hepatology Reports, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 masld GLP-1 and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) | Current Hepatology Reports in your area.
Beyond GLP-1: The promise of polyagonists in MASLD and MASH—A systematic review of randomized trials
27.58
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
27.94
MASLD (Nonalcoholic Fatty Liver Disease)
23.44
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials
21.07
GLP-1 RA and MASLD Improvement
20.74
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
21.40
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study
26.77
